Crispr Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.0M | 96k | 62.60 |
| 2023-09-30 | $4.2M | 93k | 45.39 |
| 2023-06-30 | $3.7M | 82k | 45.23 |
| 2023-03-31 | $3.7M | 82k | 45.23 |
| 2022-12-31 | $3.1M | 76k | 40.65 |
| 2022-09-30 | $5.0M | 76k | 65.35 |
| 2022-06-30 | $8.1M | 133k | 60.77 |
| 2022-03-31 | $7.5M | 119k | 62.77 |
| 2021-12-31 | $9.1M | 120k | 75.78 |
| 2021-09-30 | $13M | 114k | 111.93 |
| 2021-06-30 | $19M | 117k | 161.89 |
| 2021-03-31 | $17M | 141k | 121.85 |
| 2020-12-31 | $10M | 121k | 83.64 |
| 2020-09-30 | $10M | 121k | 83.64 |
| 2020-06-30 | $10M | 139k | 73.49 |
| 2020-03-31 | $5.5M | 130k | 42.41 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas